Next-Gen Vitamin B5 Derivatives Market Size is predicted to experience a 7.4% CAGR during the forecast period for 2025-2034. Vitamin B5, or pantothenic acid, is a vital water-soluble B-complex vitamin that plays a central role in human and animal health as a precursor to coenzyme A (CoA), a molecule essential for energy production from fats, carbohydrates, and proteins, as well as the synthesis of hormones, cholesterol, and neurotransmitters. ...
Report ID: 3247 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global GMP-Grade IVT Enzymes for Therapeutic RNA Market Size is valued at USD 361.9 Mn in 2024 and is predicted to reach USD 923.0 Mn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. GMP-grade IVT (In Vitro Transcription) enzymes are essential for producing therapeutic RNA including mRNA used in vaccines, gene therapies, and other RNA-based treatments. Manufactured under strict Good Manufacturing Practice (GMP) standard...
Report ID: 3248 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global Peptide CDMO 2.0 Market Size is predicted to grow at a 12.9% CAGR during the forecast period for 2025-2034. The next generation of contract development and manufacturing organizations (CDMOs) specializing in peptide-based therapies is known as Peptide CDMO 2.0. It goes beyond conventional services by combining cutting-edge technologies, creative procedures, and tactical partnerships to speed up drug development and production. By op...
Report ID: 3242 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Next-Generation ELISA (ELISA 2.0) Market Size is predicted to grow at a 9.6 % CAGR during the forecast period for 2025-2034. The next-generation enzyme-linked immunosorbent assay (ELISA) is an advanced modification of the conventional technique intended to overcome its drawbacks in terms of multiplexing, sensitivity, and specificity. These contemporary platforms provide highly accurate and reliable biomolecule analysis by incorporating t...
Report ID: 3241 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Living Therapeutic Agents (LTA) Market Size is valued at US$ 116.5 Bn in 2024 and is predicted to reach US$ 364.8 Bn by the year 2034 at an 12.5% CAGR during the forecast period for 2025-2034. Living therapeutic agents (LTAs) are used to stop, help, and take care of many sicknesses, like cancer, problems with the body's defense system, issues with how the body uses food, and brain problems. These helpers, such as changed bacteria, viruses, and...
Report ID: 3228 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Non-surgical Skin Tightening Market Size is valued at US$ 3.3 Bn in 2024 and is predicted to reach US$ 10.7 Bn by the year 2034 at an 12.8% CAGR during the forecast period for 2025-2034. Non-surgical skin tightening is referred to as a minimally invasive procedure that utilises targeted energy to heat the deeper layers of the skin, encouraging the production of collagen and elastin. This process gradually enhances the texture and tone of the s...
Report ID: 3233 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global Real-Time Prescription Drug Market Size is predicted to grow at an 14.8% CAGR during the forecast period for 2025-2034. With integrated digital networks linking doctors, pharmacists, insurers, and patients, prescriptions are recorded, validated, and monitored promptly. This revolutionary idea in healthcare is known as "real-time prescription drug. Real-time prescription monitoring minimises the risk of overprescribing, fraudulent activity...
Report ID: 3227 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Osteoarthritis Gene Therapy Market Size is valued at US$ 1.4 Bn in 2024 and is predicted to reach US$ 4.0 Bn by the year 2034 at an 11.7% CAGR during the forecast period for 2025-2034. Gene therapy for osteoarthritis involves the direct delivery of therapeutic genes into affected joints. This approach aims to combat the disease on a molecular level by reducing inflammation, promoting cartilage regeneration, and slowing overall disease progress...
Report ID: 3223 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Central Fill Pharmacy Automation Market Size is valued at US$ 0.6 Bn in 2024 and is predicted to reach US$ 1.5 Bn by the year 2034 at an 9.5% CAGR during the forecast period for 2025-2034. Central Fill Pharmacy Automation represents a fundamental shift in the pharmacy retail model. It leverages robotics and software to create a more efficient, accurate, and scalable prescription fulfilment system, enabling the modern pharmacist to transition f...
Report ID: 3224 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Global Alzheimer Biomarker Based Diagnostic Market Size is valued at US$ 864.3 Mn in 2024 and is predicted to reach US$ 1,788.6 Mn by the year 2034 at an 7.9% CAGR during the forecast period for 2025-2034. The Alzheimer's Disease Diagnostic Biomarker is mainly applied to figure out and confirm a diagnosis of Alzheimer's disease clinically and accurately using biomarkers - specifically, the amyloid-beta, tau, and neurofilament light chains. These...
Report ID: 3221 |
Delivery: Immediate |
Published: October 2025 |
No. of Pages: 180
Pharmaceuticals